MMEA
PRCT icon

Main Management ETF Advisors’s Procept Biorobotics PRCT Stock Holding History

Main Management ETF Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-29,754
Closed -$936K – 172
2025
Q4 		$936K Buy
29,754
+304
+1% +$10.1K 0.03% 105
2025
Q3 		$1.05M Buy
29,450
+17,722
+151% +$809K 0.04% 103
2025
Q2 		$676K Buy
11,728
+192
+2% +$10.9K 0.03% 120
2025
Q1 		$672K Sell
11,536
-568
-5% -$38.8K 0.03% 107
2024
Q4 		$975K Sell
12,104
-1,088
-8% -$93K 0.04% 63
2024
Q3 		$1.06M Buy
+13,192
New +$937K 0.05% 58

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Main Management ETF Advisors's PRCT Position: Q1 2026 in Review

Main Management ETF Advisors sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 29,754 shares — an estimated $936K sold.

Main Management ETF Advisors first reported a position in PRCT in Q3 2024 and held it in 6 quarters. The position peaked at $1.06M in Q3 2024. 257 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Main Management ETF Advisors reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
  • Main Management ETF Advisors sold 29,754 Procept Biorobotics shares in Q1 2026, an estimated $936K.
  • Main Management ETF Advisors first reported a position in Procept Biorobotics in Q3 2024 and held it in 6 quarters.
  • Main Management ETF Advisors's Procept Biorobotics position peaked at $1.06M in Q3 2024.
  • 257 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Main Management ETF Advisors's 13F filing for Q1 2026, filed 15 May 2026.